Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

By Riccardo Lencioni, D. Cioni, L. Crocetti, C. Franchini, C. Pina, J. Lera, C. Bartolozzi. Radiology, 2005

842 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Hepatocellular carcinoma: a review (2016, background): “Microwave ablation Microwave ablation (MWA) can be utilized both percutaneously and intraoperatively and is a potentially curative ablative procedure.(137) It is a method very similar to RFA, except MWA utilizes electromagnetic waves with frequencies >900 kHz to irradiate and ablate tumor foci.”
Novel advancements in the management of hepatocellular carcinoma in 2008. (2008, background): “The best results obtained in series of HCC patients treated by percutaneous ethanol injection (PEI) or radiofrequency ablation (RF) provide 5-yr survival rates of 40–70% [91,92].”
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010, background): “9% [299–301, 304].”
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy (2023, background): “4), in whom complete responses can be achieved in ~95–100% of patients 205 (Table 3).”